Common IBD Meds Acquitted in Severe COVID Outcomes

(MedPage Today) -- Both biologics and mesalamine/sulfasalazine were not linked to severe COVID-19 outcomes in inflammatory bowel disease (IBD) patients, according to findings from the ongoing global SECURE-IBD trial.
There was no association between...